ATE405644T1 - Verfahren zur herstellung und reinigung von erythropoietin - Google Patents

Verfahren zur herstellung und reinigung von erythropoietin

Info

Publication number
ATE405644T1
ATE405644T1 AT02027952T AT02027952T ATE405644T1 AT E405644 T1 ATE405644 T1 AT E405644T1 AT 02027952 T AT02027952 T AT 02027952T AT 02027952 T AT02027952 T AT 02027952T AT E405644 T1 ATE405644 T1 AT E405644T1
Authority
AT
Austria
Prior art keywords
producing
purifying
purifying erythropoietin
erythropoietin
glycoproteins
Prior art date
Application number
AT02027952T
Other languages
English (en)
Inventor
Michael Bavand
Horst Blasey
Original Assignee
Bioceuticals Arzneimittel Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32319603&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE405644(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bioceuticals Arzneimittel Ag filed Critical Bioceuticals Arzneimittel Ag
Application granted granted Critical
Publication of ATE405644T1 publication Critical patent/ATE405644T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/505—Erythropoietin [EPO]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT02027952T 2002-12-13 2002-12-13 Verfahren zur herstellung und reinigung von erythropoietin ATE405644T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02027952A EP1428878B1 (de) 2002-12-13 2002-12-13 Verfahren zur Herstellung und Reinigung von Erythropoietin

Publications (1)

Publication Number Publication Date
ATE405644T1 true ATE405644T1 (de) 2008-09-15

Family

ID=32319603

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02027952T ATE405644T1 (de) 2002-12-13 2002-12-13 Verfahren zur herstellung und reinigung von erythropoietin

Country Status (8)

Country Link
EP (1) EP1428878B1 (de)
AT (1) ATE405644T1 (de)
CY (1) CY1108571T1 (de)
DE (1) DE60228460D1 (de)
DK (1) DK1428878T3 (de)
ES (1) ES2312523T3 (de)
PT (1) PT1428878E (de)
SI (1) SI1428878T1 (de)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7173003B2 (en) 2001-10-10 2007-02-06 Neose Technologies, Inc. Granulocyte colony stimulating factor: remodeling and glycoconjugation of G-CSF
US7157277B2 (en) 2001-11-28 2007-01-02 Neose Technologies, Inc. Factor VIII remodeling and glycoconjugation of Factor VIII
US7696163B2 (en) 2001-10-10 2010-04-13 Novo Nordisk A/S Erythropoietin: remodeling and glycoconjugation of erythropoietin
US7214660B2 (en) 2001-10-10 2007-05-08 Neose Technologies, Inc. Erythropoietin: remodeling and glycoconjugation of erythropoietin
US8008252B2 (en) 2001-10-10 2011-08-30 Novo Nordisk A/S Factor VII: remodeling and glycoconjugation of Factor VII
US7795210B2 (en) 2001-10-10 2010-09-14 Novo Nordisk A/S Protein remodeling methods and proteins/peptides produced by the methods
DE60336555D1 (de) 2002-06-21 2011-05-12 Novo Nordisk Healthcare Ag Pegylierte glykoformen von faktor vii
AU2004221824B2 (en) 2003-03-14 2009-08-27 Ratiopharm Gmbh Branched water-soluble polymers and their conjugates
CA2522345A1 (en) 2003-04-09 2004-11-18 Neose Technologies, Inc. Glycopegylation methods and proteins/peptides produced by the methods
US8791070B2 (en) 2003-04-09 2014-07-29 Novo Nordisk A/S Glycopegylated factor IX
US7932364B2 (en) 2003-05-09 2011-04-26 Novo Nordisk A/S Compositions and methods for the preparation of human growth hormone glycosylation mutants
WO2005012484A2 (en) 2003-07-25 2005-02-10 Neose Technologies, Inc. Antibody-toxin conjugates
US8633157B2 (en) 2003-11-24 2014-01-21 Novo Nordisk A/S Glycopegylated erythropoietin
US20080305992A1 (en) 2003-11-24 2008-12-11 Neose Technologies, Inc. Glycopegylated erythropoietin
US20060040856A1 (en) 2003-12-03 2006-02-23 Neose Technologies, Inc. Glycopegylated factor IX
US7956032B2 (en) 2003-12-03 2011-06-07 Novo Nordisk A/S Glycopegylated granulocyte colony stimulating factor
NZ548123A (en) 2004-01-08 2010-05-28 Novo Nordisk As O-linked glycosylation of peptides
DE102004027816A1 (de) * 2004-06-08 2006-01-05 Bioceuticals Arzneimittel Ag Verfahren zur Reinigung von Erythropoietin
WO2006010143A2 (en) 2004-07-13 2006-01-26 Neose Technologies, Inc. Branched peg remodeling and glycosylation of glucagon-like peptide-1 [glp-1]
WO2006031811A2 (en) 2004-09-10 2006-03-23 Neose Technologies, Inc. Glycopegylated interferon alpha
EP1814573B1 (de) 2004-10-29 2016-03-09 ratiopharm GmbH Remodellierung und glykopegylierung von fibroblasten-wachstumsfaktor (fgf)
CA2593682C (en) 2005-01-10 2016-03-22 Neose Technologies, Inc. Glycopegylated granulocyte colony stimulating factor
CA2595676A1 (en) * 2005-01-25 2006-08-03 Apollo Life Sciences Limited Molecules and chimeric molecules thereof
US20060246544A1 (en) * 2005-03-30 2006-11-02 Neose Technologies,Inc. Manufacturing process for the production of peptides grown in insect cell lines
US9187546B2 (en) 2005-04-08 2015-11-17 Novo Nordisk A/S Compositions and methods for the preparation of protease resistant human growth hormone glycosylation mutants
WO2006127910A2 (en) 2005-05-25 2006-11-30 Neose Technologies, Inc. Glycopegylated erythropoietin formulations
US20080255026A1 (en) 2005-05-25 2008-10-16 Glycopegylated Factor 1X Glycopegylated Factor Ix
US20070105755A1 (en) 2005-10-26 2007-05-10 Neose Technologies, Inc. One pot desialylation and glycopegylation of therapeutic peptides
US20090048440A1 (en) 2005-11-03 2009-02-19 Neose Technologies, Inc. Nucleotide Sugar Purification Using Membranes
EP2013224A2 (de) * 2006-04-27 2009-01-14 Syddansk Universitet Verfahren zur isolierung und analyse von sialylierten und phosphorylierten peptiden
CN101516388B (zh) 2006-07-21 2012-10-31 诺和诺德公司 通过o-联糖基化序列的肽的糖基化
US8969532B2 (en) 2006-10-03 2015-03-03 Novo Nordisk A/S Methods for the purification of polypeptide conjugates comprising polyalkylene oxide using hydrophobic interaction chromatography
JP5065391B2 (ja) * 2006-12-06 2012-10-31 日本ケミカルリサーチ株式会社 ヒトエリスロポエチンの製造方法
EP2144923B1 (de) 2007-04-03 2013-02-13 BioGeneriX AG Behandlungsverfahren mit glycopegyliertem g-csf
US20100129932A1 (en) * 2007-06-05 2010-05-27 Loennberg Maria Determination of Isoerythropoietins
WO2008154639A2 (en) 2007-06-12 2008-12-18 Neose Technologies, Inc. Improved process for the production of nucleotide sugars
US8207112B2 (en) 2007-08-29 2012-06-26 Biogenerix Ag Liquid formulation of G-CSF conjugate
US20130189239A1 (en) 2008-02-27 2013-07-25 Novo Nordisk A/S Conjugated Factor VIII Molecules
DE102008002209A1 (de) 2008-06-04 2009-12-10 Evonik Degussa Gmbh Verfahren zur Aufreinigung von Erythropoietin
CA2736141C (en) 2008-09-23 2018-03-20 F. Hoffmann-La Roche Ag Purification of erythropoietin
KR20120117728A (ko) 2009-09-23 2012-10-24 바이오제너릭스 에이지 재조합 인간 에리트로포이에틴(ｅｐｏ)의 정제 방법, 이렇게 정제된 ｅｐｏ 및 이를 포함하는 약학적 조성물
WO2011063195A2 (en) * 2009-11-20 2011-05-26 Dr. Reddy's Laboratories Ltd. Purification of modified cytokines
EP4328305A3 (de) * 2009-12-18 2024-08-14 CSL Ltd. Verfahren zur reinigung von polypeptiden
EP2691411B1 (de) 2011-03-29 2020-02-26 GlaxoSmithKline LLC Puffersystem zur proteinreinigung
KR101443257B1 (ko) * 2011-10-18 2014-09-19 주식회사 종근당 낮은 등전점을 갖는 에리스로포이에틴 유사체의 정제방법
US20150065689A1 (en) 2012-04-10 2015-03-05 Dr. Reddy's Laboratories Limited Single step fractionation method
US10066001B2 (en) 2013-03-15 2018-09-04 Apotex Inc. Enhanced liquid formulation stability of erythropoietin alpha through purification processing
CN115032317B (zh) * 2022-06-29 2024-03-26 科兴生物制药股份有限公司 重组人促红细胞生成素的检测方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL79176A (en) * 1985-06-20 1992-06-21 Kirin Amgen Inc Process for the recovery of erythropoietin from a fluid
AU7729194A (en) * 1993-09-15 1995-04-03 Alpha Therapeutic Corporation Alpha1-acid glycoprotein purification process and product
IL117849A (en) * 1995-04-14 2002-07-25 Lepetit Spa Chromatographic process for clearing glycoproteins
IL118201A (en) * 1995-05-11 2004-12-15 Roche Diagnostics Gmbh Preparation comprising a protein with human erythropoietin activity which is free of serum and non-recombinant mammalian protein and process for the preparation thereof
RU2145610C1 (ru) * 1998-12-09 2000-02-20 Общество с ограниченной ответственностью "Протеиновый контур" Способ очистки рекомбинантного эритропоэтина человека
SI1453857T1 (sl) * 2001-11-28 2015-01-30 Sandoz Ag Kromatografsko čiščenje rekombinantnega človeškega eritropoetina

Also Published As

Publication number Publication date
PT1428878E (pt) 2008-11-18
CY1108571T1 (el) 2014-04-09
DE60228460D1 (de) 2008-10-02
SI1428878T1 (sl) 2009-02-28
DK1428878T3 (da) 2008-12-08
EP1428878A1 (de) 2004-06-16
ES2312523T3 (es) 2009-03-01
EP1428878B1 (de) 2008-08-20

Similar Documents

Publication Publication Date Title
DE60228460D1 (de) Verfahren zur Herstellung und Reinigung von Erythropoietin
DE69939901D1 (de) Verfahren und materialien zur herstellung von glucosamin
DE60323340D1 (de) Verfahren zur herstellung interferierender rna-moleküle in säugetierzellen und therapeutische anwendungen solcher moleküle
ATE553125T1 (de) Herstellung eines multimeren proteins durch zellfusionsverfahren
ATE470702T1 (de) Verfahren zur herstellung von permanenten humanen zelllinien
DE60232773D1 (de) Verfahren zur Herstellung von Membran-Elektrode-Anordnungen für Brennstoffzellen
DE60030988D1 (de) Verfahren zur Herstellung Von L-Aminosäuren durch Erhöhung des zellulären NADPH
DE60025015D1 (de) Verfahren zur herstellung von rekombinanten proteinen mittels inhibitoren von apoptose
DE60313188D1 (de) Verfahren und medien zur kontrolle der sialysierung von proteinen, die von säugetierzellen produziert werden
DE69737023D1 (de) Methode zur behandlung von krebs und pathogenen infektionen unter verwendung von antigen-präsentierenden zellen beladen mit rna
ATE334218T1 (de) Verfahren zur gleichzeitigen herstellung von xylitol und ethanol
DE60230677D1 (de) Verfahren und materialien zur herstellung organischer produkte in zellen von candida-spezies
DE60334887D1 (de) Verfahren zur induzierung der differenzierung in stammzellen, verfahren zur erzeugung von gewebe mit von mikroorganen und stammzellen abgeleiteten gerüstmatrizes, verfahren zur herstellung adulter stammzellen und verfahren zur kontinuierlichen erzeugung von stammzellen mittels implantation von mikroorganen als quellen für stammzellen
ATE278024T1 (de) Methode zur herstellung von rekombinanten zellen
ATE468390T1 (de) System und verfahren zur produktion von antikörpern in der pflanzenzellkultur
DE10390418D2 (de) Verfahren zur Herstellung von rekombinanten Proteinen in Mikroorganismen
ATE279441T1 (de) Verfahren zur herstellung von genetisch veränderten lymphozyten vorläuferzellen von wirbeltieren und deren gebrauch zur produktion von heterologen bindeproteinen
DE602006018634D1 (de) Transformierte Hefezellen UND VERFAHREN ZUR HERSTELLUNG VON FREMDPROTEIN
PL367306A1 (pl) Szczepionki na bazie autologicznych komórek T i sposoby ich otrzymywania
DE60211772D1 (de) Verfahren zur Herstellung von Proteine
DE602006018054D1 (de) Translationselongationsfaktor-promotor aus pichia pastoris und verfahren zur herstellung von rekombinantem protein unter verwendung davon
DE60309847D1 (de) Zwischenprodukte und verfahren zur herstellung von heptapeptid-oxytocinanaloga
DE69939876D1 (de) Methoden zur massenkultivierung von zellen die rekombinantes menschliches erythropoietin produzieren
ATE522543T1 (de) Verfahren zur herstellung von reifem, rekombinantem milben-i-allergen
DE60334372D1 (de) Verfahren zur herstellung von gewebekonstrukten

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1428878

Country of ref document: EP